Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Andres Alvarez, MD, PhD, EMHA
Research Director
Baptist MD Anderson Clinical Trials
Clinical Trial ID: NCT07421167
A study to assess the tolerability of ianalumab (VAY736) with investigator choice thrombopoietin receptor against (IC TPO-RA) in patients with primary immune thrombocytopenia
Status
Open
Conditions
Other Hematopoietic
Phases
2 (Cancer Control)
Age Group
Adult
Main Investiagtor
Antunez de Mayolo, Jorge
Practice
Other
Scope
National
Nct ID Number
NCT07421167
Secondary Trial ID Number
CVAY736Q1US01
Keywords
Treatment